CORDIS Project
Funding breakdown and partner intelligence are Premium
Sign in and upgrade to Premium for EU contribution totals, consortium analytics, OpenAlex research context, and AI summaries. · 0 consortium intelligence fields visible of 1
Start free • Cancel anytime • 14-day refund guarantee
This project aims to establish regulatory frameworks for gene therapy clinical trials in Uganda and Tanzania, addressing the need for safe and effective treatments for chronic diseases like HIV and Sickle Cell Anemia. It includes capacity building for researchers and regulators.
Gene therapy advancements have shown promise in treating chronic conditions like HIV and Sickle cell Anaemia and have the potential to greatly reduce the burden of disease in Sub-Saharan Africa which is plagued with a double burden of communicable and non-communicable diseases.
These treatments have the potential to reduce the burden of disease for the populations for which they are targeted and the cost of treatments for governments.
In Sub-Saharan Africa, there are largely no or unclear regul…
Partner organizations (coordinator is shown above), with normalized type and CORDIS activity type. Guests see up to 4 partners.
UGANDA NATIONAL COUNCIL FOR SCIENCE AND TECHNOLOGY
Uganda, Kampala
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
JOINT CLINICAL RESEARCH CENTRE
Uganda, KAMPALA
Type: Research institute
Activity type: Research Organisations
SME: No
Uganda, Central Division
Type: Public body
Activity type: Public bodies (excluding Research Organisations and Secondary or Higher Education Establishments)
SME: No
Tanzania, DAR ES SALAAM
Type: University / higher education
Activity type: Higher or Secondary Education Establishments
SME: No
Similar projects, consortium collaboration history, frequent partners, and OpenAlex research context.
Guests see up to 5 EuroSciVoc fields.
Guests see up to 5 topics.
Guests see up to 5 keywords.
